Vicki Nicely Clinical Research Mgr

Treatments for Cardiovascular Disease

Our research company at present focuses primarily on treatments for cardiovascular disease. Current studies include proposed therapies for pre-diabetes, coronary artery disease and obesity, cholesterol lowering medications, new medicines to treat atrial fibrillation and a new treatment for patients with congestive heart failure and anemia.

We also conduct device trials, including pacemaker, defibrillators, resynchronization therapy and carotid stents.

All office visits, labs, procedures and medication are at no cost to the patient with the exception of some device trials. Post-market device studies (implant & visits) are covered by your insurance. Some studies also pay for time and travel expenses. The majority of our trials also involve free lifestyle counseling with regard to diet and exercise.

You may be eligible to participate in a research study if you have been diagnosed with:

• Atrial Fibrillation
• High Cholesterol
• Coronary Artery Disease and Obesity
• Normal Cholesterol with high CRP
• Coronary Artery Disease and GERD
• Congestive Heart Failure and Anemia
• Hypertension

OR, recommended for device treatment (ICD/CRT therapy)

For more information about our ongoing or upcoming clinical trials, please contact us at:

TCA Research
(985) 892-2550
Or email:
vicki@tcaway.com